Fetal Bovine Serum (FBS) Market Size, Growth, SWOT Analysis, Forecast to 2033

Fetal Bovine Serum (FBS) Market By Application (Cell-based research, Cell culture media, Drug discovery, Vaccine development, Others), By End-User (Diagnostic labs, Research & academic institutes, Biotechnology & pharmaceutical industries, Others), By Product Type (Chromatographic, Stem cell, Dialyzed fetal bovine serum, Charcoal stripped, Others), By Region: Global Data Interpretation, Analysis and Forecast 2024-2033

Report Code : 34
Published Date : 10/07/2024
Number of Pages : 207
Report Format : PDF

Description

The global Fetal Bovine Serum (FBS) market size generated approximately $1.42 Billion in revenue in 2023 and is projected to reach $5.17 Billion by 2033, reflecting a forecasted compound annual growth rate (CAGR) of 13.8%.

Fetal Bovine Serum (FBS) Market Overview

Fetal Bovine Serum (FBS) is derived from the blood of bovine fetuses, typically collected using a closed collection system at slaughterhouses. FBS is widely used as a supplement in basal growth media for cell culture due to its rich content of embryonic growth-promoting factors. It offers several advantages, including low molecular weight nutrients, macromolecular proteins, carrier proteins for water-insoluble components, hormones, and attachment factors essential for in vitro cell growth.

Fetal Bovine Serum (FBS) Market Drivers and Growth Projections

  1. High Protein Content and Acceptance in Research: FBS is highly valued in the research industry for its rich protein content and over 1000 components, such as hormones, growth factors, enzymes, carriers, energy sources, and proteins for transfer and binding. This makes it a preferred supplement compared to other serums.
  2. Growing Demand in Pharmaceutical and Drug Development: The increasing demand for FBS in research and development, particularly in pharmaceuticals and drug development, is a significant market driver. The rising prevalence of acute and chronic diseases worldwide, coupled with the effectiveness of FBS in vaccine development, is expected to boost its adoption during the forecast period.
  3. Rising Population and Healthcare Pressure: The growing global population and increasing pressure on the healthcare sector are leading to higher use of FBS, further fueling market growth.

Fetal Bovine Serum (FBS) Market Challenges

  1. Ethical Concerns: The primary challenge facing the FBS market is the ethical concerns surrounding its collection process. These concerns may hinder market growth as consumers and organizations seek more humane alternatives.
  2. Pricing Volatility and Geographical Disparities: The volatile pricing of FBS and disparities in sourcing across different geographical regions also pose challenges to market stability and growth.

Fetal Bovine Serum (FBS) Market Opportunities

Investments in Life Sciences Research: Increasing investments in life sciences research, especially in medical research aimed at understanding diseases and developing new treatments, present growth opportunities for the FBS industry. For example, cancer research, a major focus due to its status as a leading cause of death, drives demand for FBS.

Fetal Bovine Serum (FBS) Market Challenges

Demand for Animal-Free Alternatives: The growing demand for animal-free serums and alternative treatments, such as human serum and equine serum, may limit FBS market growth. The research community is evolving, and market players may face challenges as preferences shift.

Report Scope:

Report Attributes Report Description
Report Name Fetal Bovine Serum (FBS) Market Research Report
Market Size in 2023 USD 1.42 Billion
Market Size By 2033 USD 5.17 Billion
CAGR (2024-2033) 13.8%
Base Year 2023
Historic Period 2020 to 2022
Forecast Period 2024 – 2033
Market Segments By Application, By End-user, By Product Type, and By Region.
Comeptitive Landscape Thermo Fisher Scientific Inc., Merck KGaA (Sigma-Aldrich), Moregate Biotech, Atlanta Biologicals, Inc., Gemini Bio-Products, Bovogen Biologicals Pty Ltd, Serana, GE Healthcare, Corning Incorporated, Lonza Group, HiMedia Laboratories, Biowest, Biological Industries, Zhejiang Tianhang Biotechnology, TCS Biosciences, Hyclone, Gibco, PAN-Biotech
Regional Analysis North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Customization Scope Free report customization Available after purchase. Report segments, country based Customization will be provided. Moreover, additional customization can be done based on the requirements.

Fetal Bovine Serum (FBS) Market: Competitive Analysis

Key companies in the global fetal bovine serum market include:

  • Thermo Fisher Scientific Inc.
  • Merck KGaA (Sigma-Aldrich)
  • Moregate Biotech
  • Atlanta Biologicals, Inc.
  • Gemini Bio-Products
  • Bovogen Biologicals Pty Ltd
  • Serana
  • GE Healthcare
  • Corning Incorporated
  • Lonza Group
  • HiMedia Laboratories
  • Biowest
  • Biological Industries
  • Zhejiang Tianhang Biotechnology
  • TCS Biosciences
  • Hyclone
  • Gibco
  • PAN-Biotech

Fetal Bovine Serum (FBS) Market: Segmentation Analysis

By Application:

  • Cell-based research
  • Cell culture media
  • Drug discovery
  • Vaccine development
  • Others

Cell culture media led the market in 2022, accounting for over 29% of total revenue, driven by its role in providing a safe and supportive environment for cell culture procedures.

By End-User:

  • Diagnostic labs
  • Research & academic institutes
  • Biotechnology & pharmaceutical industries
  • Others

By Product Type:

  • Chromatographic
  • Stem cell
  • Dialyzed fetal bovine serum
  • Charcoal stripped
  • Others

Stem cell segment held around 35% of the market share, reflecting the growing reliance on stem cells for modern medical research and health industries.

Fetal Bovine Serum (FBS) Market: Regional Analysis

North America and Europe are the largest markets for FBS, driven by substantial bovine populations and significant research and development activities. Asia Pacific offers promising growth opportunities, particularly in Australia, due to its large cattle population and government support for research and development.

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • Thermo Fisher Scientific Inc.
  • Merck KGaA (Sigma-Aldrich)
  • Moregate Biotech
  • Atlanta Biologicals, Inc.
  • Gemini Bio-Products
  • Bovogen Biologicals Pty Ltd
  • Serana
  • GE Healthcare
  • Corning Incorporated
  • Lonza Group
  • HiMedia Laboratories
  • Biowest
  • Biological Industries
  • Zhejiang Tianhang Biotechnology
  • TCS Biosciences
  • Hyclone
  • Gibco
  • PAN-Biotech

FREQUENTLY ASK QUESTIONS

We offer risk-free purchases, allowing you to explore our market reports online through a telephonic conference without any commitment to purchase. You can request a free sample and topline numbers to assess the quality and content of the report before making a purchase decision. Our extensive portfolio of reports undergoes rigorous quality checks. As an accredited market research company specializing in almost all industry verticals, we prioritize accuracy and reliability.
Yes, we provide free customizations within the scope of the research to meet your specific requirements. Majority our client associations involve customized market reports. Clients receive complimentary access to pre-sale analyst support for discussing customized requirements and recommendations.